Sergio Lamprecht

Prof. Sergio Lamprecht


Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 February 2018 in Cancers
Verified
Journal Article
Open access
PDF file
SLSergio Lamprecht
Sergio Lamprecht
ISIna SigalBatikoff
Ina SigalBatikoff
SSShraga Shany
Shraga Shany
NANaim Abu-Freha
Naim Abu-Freha
ELEduard Ling
Eduard Ling
AFAlexander Fich
Alexander Fich
It is well recognized that cancer cells subvert the phenotype of stromal naïve fibroblasts and instruct the neighboring cells to sustain their growth agenda. The mechanisms underpinning the switch of fibroblasts to cancer-associated fibroblasts (CAFs) are the focus of intense investigation. One of the most significant hallmarks of the biological identity of CAFs is that their tumor-promoting phenotype is stably maintained during in vitro and ex vivo propagation without the continual interaction with the adjacent cancer cells. In this review, we discuss robust evidence showing that the master cytokine Transforming Growth Factor-β1 (TGFβ-1) is a prime mover in reshaping, via epigenetic switches, the phenotype of stromal fibroblasts to a durable state. We also examine, in detail, the pervasive involvement of TGFβ-1 signaling from both cancer cells and CAFs in fostering cancer development, taking colorectal cancer (CRC) as a paradigm of human neoplasia. Finally, we review the stroma-centric anticancer therapeutic approach focused on CAFs—the most abundant cell population of the tumor microenvironment (TME)—as target cells.

1 December 2016 in Anticancer Research
Verified
Journal Article
Open access
PDF file
SSShraga Shany
Shraga Shany
ISIna Sigal-Batikoff
Ina Sigal-Batikoff
SLSergio Lamprecht
Sergio Lamprecht
The multifaceted involvement of the active vitamin D metabolite 1,25-dihydroxyvitamin D3 (henceforth referred to by the synonyms 1,25(OH)2D3, calcitriol or vitamin D) in blunting the growth of cancer cells is amply recognized. In this review we focused our attention on the cross-talk between 1,25 (OH)2D3 and the tumor microenvironment (TME), signaling out stromal cancer-associated fibroblasts (CAFs), the most abundant TME population, as a target for calcitriol anticancer action. In view of the commonality of the phenotypic signature in myofibroblasts, resident in the cancer stroma and in non-neoplastic fibrotic loci, we examined modes of action of vitamin D in non-neoplastic chronic diseases and in cancer to assess mechanistic similarities and divergences. A constant observation was that 1,25(OH)2D3 or synthetic ligands via the active vitamin D receptor (VDR) impede transforming growth factor (TGF)-β/mothers against decapentaplegic homologs (SMADs) signaling in myofibroblasts regardless of the initiating insult. The translational impact of 1,25(OH)2D3 in targetting stromal CAFs is discussed.

9 September 2016 in Anticancer Research
Verified
Journal Article
Closed access
PDF file
ELEduard Ling
Eduard Ling
ARAmit Ringel
Amit Ringel
ISIna Sigal-Batikoff
Ina Sigal-Batikoff
NANaim Abu-Freha
Naim Abu-Freha
HVHananya Vaknine
Hananya Vaknine
SLSergio Lamprecht
Sergio Lamprecht
Background/Aim: Cancer-associated fibroblasts (CAFs) play an important role in tumor development and progression. The prevailing consensus favors the view that a specific epigenetic signature underpins the stable CAF phenotype. The aim of the present study was to assess global DNA methylation in CAFs during the adenoma–carcinoma sequence in non-familial sporadic human colorectal cancer (CRC). Patients and Methods: Immunohistochemical staining of nuclear 5-methylcytosine (5’-meCyt) was performed in matched samples of colonic tumor tissue and normal colonic mucosa excised from six patients with adenomas and four with adenocarcinomas. The staining intensity was expressed semi-quantitatively as the immunohistochemical staining score (ISS). Results: ISS values of human colonic CAFs and adenomatous samples were 14.00±2.2 and 14.08±1.8, respectively, showing no statistically significant difference. In contrast, a marked trend was found towards global DNA hypomethylation in CAFs from adenocarcinomatous specimens compared to matched normal mucosa: ISS: 9.25±2.44 (range=6-11) vs. 16.17±0.75, respectively, p<0.03. Conclusion: Final stages of cancer development in CRC are associated with global DNA hypomethylation in stromal CAFs.

1 April 2015
Verified
Journal Article
Closed access
JDJohn G Delinasios
John G Delinasios
FAFlora Angeli
Flora Angeli
GKGeorge Koumakis
George Koumakis
SKShant Kumar
Shant Kumar
WKWen-Hui Kang
Wen-Hui Kang
GDGeorge J Delinasios
George J Delinasios

1 August 2016 in Trends in Cancer
Verified
Journal Article
Closed access
SLSergio Lamprecht
Sergio Lamprecht
AFAlexander Fich
Alexander Fich

25 June 2015 in Carcinogenesis
Verified
Journal Article
Open access
PDF file
SLSergio Lamprecht
Sergio Lamprecht
AFAlexander Fich
Alexander Fich
A prominent model of tumor progression posits that normal self-renewing and multipotent stem cells(SCs) are the initial target of transformation. This view has been robustly challenged by the recurring observation that transit-amplifying cells and differentiated progenitors can initiate neoplasia outside the SC zone thus qualifying as cancer cells-of-origin. The emerging concept is that a cancer SC and a cancer cell-of-origin are not necessarily the same cell. Importantly, progenitor cells were shown to possess remarkable plasticity and to revert, on demand, to a SC-like state. The present review revisits our early hypothesis that colonic progenitors acquiring a mutant adenomatous polyposis coli gene after exiting the stem zone may serve as genuine cancer cells-of-origin. New findings consonant with this view are examined, and tenable molecular and cellular mechanisms underpinning the plasticity of progenitor cells in the gastrointestinal tract and in other tissues are discussed. The translational impact of cell plasticity is addressed, and recommendations for future research are advanced.